Option chain shows key data for Oruka Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Oruka Therapeutics.

Oruka Therapeutics (NASDAQ:ORKA) Stock, Option Chain

Oruka Therapeutics

Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

APLD

ARDT

CVGW

ORKA

TBCH

VCEL

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

AZTR

CRKN

GCTK

GLAC

HSDT

LFWD

MASS

QBTS

QUBT

RIME

SGBX

VMAR

VRME

Why Vision Marine Technologies Shares Are Trading Higher By 68%; Here Are 20 Stocks Moving Premarket

BURU

CETX

DBGI

DOCU

FUTU

ALPS ETF Trusthen & Steers Global Realty Majors ETF

MAMA

NMHI

OGEN

OTRK

SOBR

VIRI

Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Oruka Therapeutics Inc

<a href="https://www.washingtonpost.com/technology/2025/01/15/trump-tiktok-ban-executive-order/" title="https://www.washingtonpost.com/technology/2025/01/15/trump-tiktok-ban-executive-order/">https://www.washingtonpost.com/technology/2025/01/15/trump-tiktok-ban-executive-order/</a>

Social Media

General

SNAP

Washington Post: 'Trump considers executive order hoping to 'save TikTok' from ban in U.S. law'

McKenna most recently served as President and Chief Executive Officer of Walmart International until her retirement in January 2024, where she was responsible for all aspects of Walmart's business outside the United States.

Management

Delta Air Lines Board Adds Judith Mckenna As Its Newest Member, Effective February 7, 2025

Flowco Holdings Inc. ("Flowco"), a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry, today announced the pricing of its initial public offering of 17,800,000 shares of its Class A common stock at a public offering price of $24.00 per share. In addition, the underwriters will have a 30-day option to purchase up to an additional 2,670,000 shares of Class A common stock from Flowco at the initial public offering price, less underwriting discounts and commissions. Flowco's Class A common stock is expected to begin trading on the New York Stock Exchange on January 16, 2025 under the ticker symbol "FLOC." The offering is expected to close on January 17, 2025, subject to the satisfaction of customary closing conditions.
Flowco intends to use the net proceeds that it receives from the proposed offering to redeem certain equity interests from certain non-affiliate holders, and with respect to the remainder, repay indebtedness under its existing credit agreement.

IPOs

FLOC

Flowco Announces The Pricing Of Its Initial Public Offering Of 17.8M Shares Of Its Class A Common Stock At A Public Offering Price Of $24.00 Per Share; Expected To Begin Trading On The New York Stock Exchange On January 16, 2025

Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) released its Q4 earnings on Wednesday, January 15, 2025 at 04:20 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Home BancShares missed estimated earnings by -4.0%, reporting an EPS of $0.5 versus an estimate of $0.52.
Revenue was up $12.75 million from the same period last year.
<h3>Earnings History Overview</h3>
The company missed on EPS by $0.03 in the previous quarter, leading to a 2.0% drop share price change the next day.
Here's a look at Home BancShares's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.53</td>
<td>0.49</td>
<td>0.46</td>
<td>0.45</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.50</td>
<td>0.52</td>
<td>0.49</td>
<td>0.51</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>258.90M</td>
<td>247.21M</td>
<td>240.46M</td>
<td>243.07M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>258.00M</td>
<td>254.60M</td>
<td>246.39M</td>
<td>245.62M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Home BancShares <a href="https://www.benzinga.com/quote/HOMB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

HOMB

Recap: Home BancShares Q4 Earnings

Rio Tinto Says Pilbara Iron Ore Operations Produced 328.0 Million Tonnes In 2024, With Shipments Of 328.6 Million Tonnes, Each 1% Lower Than 2023

<ul>
<li>Accelerates the tax-free spin-off of its Electronics business, now targeting November 1, 2025</li>
<li>DuPont to retain the Water business within its portfolio</li>
<li>Reaffirms fourth quarter and full year 2024 net sales, operating EBITDA and adjusted EPS financial guidance ahead of its February 11th earnings call</li>
</ul>
WILMINGTON,&nbsp;Del., Jan. 15, 2025 /PRNewswire/ -- DuPont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) today announced the acceleration of the separation of its Electronics business and is now targeting November 1, 2025 to complete the transaction. This decision recognizes the size and importance of Electronics to the overall shareholder value creation opportunity and DuPont's desire to complete the separation as quickly as possible.
Additionally, DuPont no longer intends to separate its Water business. The company evaluated all strategic alternatives and concluded the best path to generate value is for the Water business to remain in the DuPont portfolio. This also enhances DuPont's ability to continue optimizing its portfolio following the Electronics separation.
"We remain confident in the opportunity to create significant shareholder value through the separation of the Electronics business," said Ed Breen, DuPont Executive Chairman. "Achieving an independent Electronics company as soon as possible is the right decision for our shareholders."
"We remain excited about the value creation opportunity for DuPont following the Electronics separation," added Lori Koch, DuPont Chief Executive Officer. "The decision for Water to remain with DuPont provides the new organization with greater strategic flexibility over time and another high growth business alongside Healthcare. We continue to have conviction in the attractive outlook for Water and expect 2025 to be a strong year for the business."&nbsp;
Reaffirms Fourth Quarter and Full Year 2024 Financial Outlook
DuPont reaffirms its fourth quarter and full year 2024 financial guidance for net sales, operating EBITDA and adjusted EPS as provided on November 5, 2024 as part of its third quarter earnings release, including the expected continued improved performance in Water.
 &nbsp;

Guidance

Dividends

DuPont Accelerates The Tax-Free Spin-Off Of Its Electronics Business, Now Targeting November 1, 2025; To Retain The Water Business Within Its Portfolio; Reaffirms Q4 And FY24 Financial Outlook

<a href="https://hindenburgresearch.com/gratitude/" title="https://hindenburgresearch.com/gratitude/">https://hindenburgresearch.com/gratitude/</a>

Short Sellers

CVNA

RBLX

SMCI

Hindenburg Research Founder Nate Anderson Said He Has Made The Decision To Disband The Firm

As a result, the Company has decided to voluntarily revise its historical adjusted operating income for the relevant periods, resulting in a decrease in after-tax adjusted operating income of $115 million or $0.31 per Common share for the nine months ended September 30, 2024, and $24 million or $0.07 per Common share for the nine months ended September 30, 2023, compared to previously reported amounts(1).&nbsp;
These revisions had no impact to GAAP net income, book value, statutory results, or the historical or expected future cash flows of these products.

Prudential Financial Says Identified An Immaterial Error During Q4 In Application Of Adjusted Operating Income - Filing

Amphenol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) has outperformed the market over the past 15 years by 7.09% on an annualized basis producing an average annual return of 18.86%. Currently, Amphenol has a market capitalization of $85.54 billion. 
Buying $1000 In APH: If an investor had bought $1000 of APH stock 15 years ago, it would be worth $12,870.75 today based on a price of $70.95 for APH at the time of writing.
<h3>Amphenol's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736976607_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

NEXA

Nexa Resources Adopts New Dividend Policy; Targets Annual Dividend Of Up To 20% Of Free Cash Flow Pre-events, With Minimum Payment Of $0.08 Per Share

"Exceptional holiday demand and the effective execution of our strategic initiatives fueled our fourth-quarter outperformance, and gives us confidence that we will exceed our prior 2024 guidance,"&nbsp;stated Charlie Youakim, Sezzle Chairman and CEO.

SEZL

Sezzle Expects Exceeding 2024 Revenue And Income Guidance Provided In Conjunction With Its Q3 Earnings Release.

MetLife Responds To Report On Cyberattack, Says "We are aware of a cyberattack impacting Ecuador-based Fondo Genesis. As Fondo Genesis operates separately from MetLife's enterprise systems, this incident has not impacted any other parts of the MetLife business. Fondo Genesis is a financial services company operating only in Ecuador that is owned by Chilean pension manager ProVida, a subsidiary of MetLife."

Mandy Long will step down as Chief Executive Officer and from the Board of Directors, transitioning to serve as a Company advisor.
McAleenan currently serves as BigBear.ai's President.

BBAI

BigBear.ai Appoints Kevin McAleenan As CEO And Member Of  Board, Effective January 15, 2025, Succeeding Mandy Long

Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.52 by 3.85 percent. The company reported quarterly sales of $258.36 million which beat the analyst consensus estimate of $256.70 million by 0.65 percent. This is a 5.19 percent increase over sales of $245.62 million the same period last year.

Earnings Beats

Earnings Misses

Home BancShares Q4 2024 Adj EPS $0.50 Misses $0.52 Estimate, Sales $258.36M Beat $256.70M Estimate

Compass Diversified Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CODI#NYSE">CODI</a>), an owner of leading middle market businesses (the "Company" or "CODI"), announced today that on January 15, 2025, it entered into a Seventh Amended and Restated Management Services Agreement with Compass Group Management LLC, the Company's Manager (the "Amendment"). The Amendment, commencing in the first quarter beginning on January 1, 2025, restructures the management fee under the existing Management Services Agreement to consist of a base management fee and an incentive management fee. Pursuant to the Amendment, the base management fee will be (i) 2.0% of the Company's adjusted net assets when the adjusted net assets are less than or equal to $3.5 billion (the "Initial Threshold Fee"), (ii) the Initial Threshold Fee, plus 1.25% of the amount of adjusted net assets exceeding $3.5 billion when the adjusted net assets are more than $3.5 billion but less than $10 billion, or (iii) 1.5% of the Company's adjusted net assets when the adjusted net assets are $10 billion or more.
The incentive management fee will be 0.25% of the amount of adjusted net assets exceeding $3.5 billion, when the adjusted net assets are more than $3.5 billion but less than $10 billion. The incentive management fee is only earned if the Company's annualized internal rate of return on equity for the trailing three years exceeds 12%. Such incentive management fee is also subject to approval by the Compensation Committee of the Company's Board of Directors.

CODI

Compass Diversified Enters Seventh Amended Management Services Agreement, Restructures Fees Effective Q1 2025; Base Fee 2% Up To $3.5B, 1.25% Over $3.5B to $10B, 1.5% Over $10B; Incentive Fee 0.25% Over $3.5B To $10B Subject To 12% Return Approval

O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) has outperformed the market over the past 5 years by 9.93% on an annualized basis producing an average annual return of 22.27%. Currently, O'Reilly Automotive has a market capitalization of $69.51 billion. 
Buying $100 In ORLY: If an investor had bought $100 of ORLY stock 5 years ago, it would be worth $273.27 today based on a price of $1204.04 for ORLY at the time of writing.
<h3>O'Reilly Automotive's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736975709_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ORLY

Here's How Much You Would Have Made Owning O'Reilly Automotive Stock In The Last 5 Years

Additionally, Capital Southwest's preliminary estimate of its net asset value per share as of December 31, 2024 is in the range of $16.57 to $16.62. Finally, Capital Southwest's preliminary estimate of its investment assets at fair value as of December 31, 2024 is approximately $1.7 billion.

CSWC

Capital Southwest Reveals Preliminary Estimate Of Q3 Pre-tax Net Investment Income Of $0.63 - $0.64 Per Shae; Sees Net Investment Income Of $0.62 - $0.63 Per Share; Est $0.62

Fiscal 2025 Outlook:
<ul>
<li>Net revenue growth for fiscal 2025 is expected to be down 2% to 4%, adjusting for the divestiture of the Flooring business, net revenue is expected to be up 1% to 2%;</li>
<li>Organic revenue growth is expected to be flat to up 2% versus fiscal 2024;</li>
<li>Adjusted EBITDA for fiscal 2025 is expected to be in the range of $600 million to $625 million, equating to growth of approximately 1% to 5% year-on-year;</li>
<li>Adjusted EBITDA for the first quarter of 2025 is expected to be in the range of $105 million to $115 million;</li>
<li>The core tax rate, excluding the impact of discrete items, is anticipated to be between 26% and 27% in fiscal year 2025;</li>
<li>Net interest expense for fiscal 2025 is expected to be between $120 million and $125 million;</li>
<li>Adjusted EPS (diluted) is expected to be in the range of $3.90 to $4.20, equating to a range of up 2% to 9% year-on-year;</li>
<li>Operating cash flow in fiscal year 2025 is expected to be between $300 million and $325 million;</li>
<li>Capital expenditures of approximately $160 million are expected in fiscal 2025, which includes approximately $40 million related to the Company's manufacturing footprint consolidation initiative.</li>
</ul>

H.B. Fuller Fiscal 2025 Outlook, Sees Net Revenue Down 2%-4%; Organic Growth Flat To Up 2%; Adjusted EBITDA $600M-$625M, Q1 $105M-$115M; Adj. EPS $3.90-$4.20 Vs $4.22 Est.; Cash Flow $300M-$325M

Taiwan Semiconductor Manufacturing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) could share more commentary on strong semiconductor demand and how a new White House administration could boost the sector when the company reports fourth-quarter financial results before <a href="https://www.benzinga.com/earnings">the market opens Thursday.</a>
Earnings Estimates: Analysts expect Taiwan Semiconductor to report fourth-quarter revenue of $26.28 billion. That&#8217;s up from $19.62 billion in last year's fourth quarter, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company has beaten analyst estimates for revenue in four straight quarters and five of the last 10 quarters overall.
Analysts expect the company to report fourth-quarter earnings per share of $2.23, up from $1.44 in last year's fourth quarter. The company beat analyst earnings per share estimates in four straight quarters and six of the last 10 quarters overall.
Guidance from the company provided after Q3 results called for fourth-quarter revenue of $26.1 billion to $26.9 billion.
What Analysts Are Saying: Strong demand for leading-edge nodes from the company could power fourth-quarter results and 2025 guidance, Goldman Sachs analyst Bruce Lu <a href="https://www.benzinga.com/25/01/42825523/taiwan-semi-likely-for-upside-backed-by-ai-demand-and-advanced-node-pricing-analyst-says">recently said.</a>
The analyst maintained a Buy rating and raised the price target from $248 to $254.
Lu sees strong momentum in artificial intelligence helping to boost revenue for Taiwan Semiconductor in 2025.
The analyst also sees a more favorable landscape for Taiwan Semiconductor against competitors like Samsung Electronics and Intel as those companies move to more advanced nodes.
Taiwan Semiconductor could raise prices and see its gross margins grow in 2025, the analyst added.
Read Also: <a href="https://www.benzinga.com/25/01/42917194/tsmc-powers-up-december-revenue-soars-ahead-of-q4-earnings-release">TSMC Powers Up: December Revenue Soars Ahead Of Q4 Earnings Release</a>
Key Items to Watch: Analysts and investors will be watching for commentary from Taiwan Semiconductor on recent reports of increased export regulations to China.
Advanced chips, including those that specialize in AI, have been a hot topic among items that are banned from being exported to China under <a href="https://www.benzinga.com/government/regulations/25/01/42897081/nvidia-and-ai-chip-stocks-brace-for-impact-as-biden-administration-considers-new-china-export-ban-report">the Biden administration</a>.
Trump is set to take office on Monday, a short time after Taiwan Semiconductor's earnings report is published. Analyst questions could center on the political conversation of the semiconductor sector and what's ahead.
The semiconductor sector saw several stocks as top performers in 2017 — Trump&#8217;s first year in the White House previously. Micron Technology and Nvidia Corporation were among the <a href="https://www.benzinga.com/general/politics/24/10/41584466/these-10-stocks-were-the-best-s-p-500-performers-in-2017-when-trump-was-president-will-history-r">10 best-performing stocks</a> in 2017 among S&amp;P 500 members.
Investors and analysts may also be looking for an update on Taiwan Semiconductor's U.S. expansion. The company expects its Arizona plant <a href="https://www.benzinga.com/government/regulations/25/01/42947562/taiwan-semiconductor-begins-4nm-chip-production-in-arizona-eyes-11-4-billion-q4-profit">to begin manufacturing </a>in 2025.
Price Action: Taiwan Semiconductor stock is up 2% to $206.06 on Wednesday versus a 52-week trading range of $100.000 to $222.20. Taiwan Semiconductor stock is up 103% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43003008/taiwan-semi-samsung-intel-may-face-stricter-us-rules-on-chip-exports-to-china-over-security-concerns">Taiwan Semi, Samsung, Intel May Face Stricter US Rules on Chip Exports to China Over Security Concerns</a></li>
</ul>
Image: Shutterstock

Previews

Tech

Taiwan Semiconductor Q4 Earnings Preview: Analysts Expect 5th Straight Beat, Will Execs Comment On Trump Impact?

The World Economic Forum's (WEF) "Global Risks Report" for 2025 paints a sobering picture of the challenges ahead. The survey, released during the <a href="https://www.benzinga.com/topic/world-economic-forum#more-news">WEF&#8217;s annual meeting in Davos</a>, Switzerland, highlights the risks of geopolitical tensions, climate change and disinformation. 
These risks call for strategies to safeguard investments while capitalizing on emerging opportunities. Here&#8217;s how some ETFs could help investors sail smoothly through each global challenge mentioned in the survey.
Armed Conflict
According to the WEF report, 23% of respondents named state-based armed conflict as the most pressing risk for 2025. Persistent geopolitical tensions, such as the Russia-Ukraine conflict and the unrest in the Middle East, have shaken global trust.
In such a dire situation, defense ETFs and global security ETFs can save the day for investors. iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>) provides exposure to U.S.-based companies in the defense sector, which could benefit from increased government spending on military capabilities. Moreover, an expense ratio of 0.4% makes it a cost-effective option. Also, a beta of 0.97% means it is at slightly lower risk than the broader market during volatility.
In addition, the SPDR S&amp;P Kensho Future Security ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FITE#NYSE">FITE</a>) focuses on innovative companies addressing global security challenges, including cybersecurity and physical defense. A glimpse of its top holdings include Viasat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>), Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) and F5 Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>). The fund boasts an expense ratio of 0.45%.
Extreme Weather
The climate crisis is intensifying the frequency and severity of weather events such as floods, heatwaves, and tornadoes. With environmental risks dominating the 10-year horizon, resilient investment strategies are the need of the hour.
Clean Energy ETFs are well-positioned to capitalize on this global challenge. Invesco Solar ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>) has holdings in solar energy companies like Enphase Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NYSE">ENPH</a>) and First Solar Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NYSE">FSLR</a>), which are poised to benefit from global decarbonization efforts.
See Also: <a href="https://www.benzinga.com/news/24/10/41594398/bill-gates-climate-innovation-model-wins-praise-from-ray-dalio-klaus-schwab-but-say-1-trillion-annua">Bill Gates&#8217; Climate Innovation Model Wins Praise From Ray Dalio, Klaus Schwab, But Say $1 Trillion Annual Funding Globally Is Not Enough</a>
Disinformation and Misinformation
For the second consecutive year, the scourge of misinformation and disinformation has been flagged by WEF as a top risk, leading to societal distrust, markets disruption, and heightened polarization. 
Many tech companies are united in their efforts to curb the spread of misinformation as well as disinformation (there is a very thin line of intentions separating the two terms). However, among those most equipped to fight this menace are cybersecurity companies. Naturally, <a href="https://www.benzinga.com/25/01/42829188/hack-attack-cybercrime-surge-fuels-demand-for-cybersecurity-etfs">ETFs focusing on the cybersecurity sector</a> stand to gain.
First Trust Nasdaq Cybersecurity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIBR#NASDAQ">CIBR</a>) focuses on companies addressing cyber threats, which often fan the fire of misinformation. Stocks of companies like Broadcom, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Crowdstrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) and Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), prominent players in the cybersecurity space, are part of this fund&#8217;s holdings. 
Media ETFs like the Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) can also benefit from media firms, which are increasingly becoming content-conscious. Media firms may benefit from investing in trusted content creation and digital information technologies.
Why ETFs Are Ideal In Turbulent Times
Insights from over 900 global risk experts, policymakers and industry leaders in September and October last year were obtained to compile WEF&#8217;s survey report. Some of the other short-term risks that the WEF's report highlights include societal polarization, cyber espionage, pollution, and inequality.
In these turbulent times, investors seek to hedge their investments instead of holding back from the market. ETFs come into the picture as flexible, cost-efficient and concern-specific instruments that allow investors to diversify their portfolios across sectors and geographies during global uncertainties.
As Carolina Klint of Marsh McLennan Europe told CNBC, "I think we're navigating an era now marked by increasing economic tensions&#8230;And I think we have to recognize the fragmentation is not a theoretical concern. It is something that we need to confront today. So, it has resulted in a more complex and uncertain trading environment." 
Building a resilient portfolio with ETFs aligned to global challenges can help investors power through 2025.
See Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/01/43010401/maximize-growth-minimize-risk-with-new-dynamic-allocation-etf">Maximize Growth, Minimize Risk With New, Dynamic Allocation ETF</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

Emerging Market ETFs

Global

ETFs

ANEW

AVGO

CIBR

CRWD

CSCO

ENPH

FFIV

FITE

FSLR

iShares Dow Jones US Aerospace & Defense Index Fund

VSAT

Davos 2025: ETFs To Tackle Geopolitical, Climate, Cyber Risks

LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on ORKA stock, giving a Buy rating today. Sam Slutsky's rating is based on ...

Strong Growth Potential for Oruka Therapeutics Driven by Robust Financials and Promising Drug Pipeline

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report), with a price t...

Positive Outlook for Oruka Therapeutics Driven by Innovative Pipeline and Financial Stability

Jefferies analyst Michael Yee has maintained their bullish stance on ORKA stock, giving a Buy rating today. Michael Yee has given his Buy rating du...

Oruka Therapeutics' Promising Long-Term Strategy and Advancements in Psoriasis Treatments Drive Buy Rating

Wedbush analyst David Nierengarten initiated coverage with a Buy rating on Oruka Therapeutics (ORKA – Research Report) today and set a price target...

Wedbush Initiates a Buy Rating on Oruka Therapeutics (ORKA)

Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Oruka Therapeutics (ORKA – Research Report). The associated price ta...

Oruka Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating with $45 Target Price

Oruka Therapeutics, Inc. ( ($ORKA) ) has released its Q3 earnings. Here is a breakdown of the information Oruka Therapeutics, Inc. presented to its...

Oruka Therapeutics: Strong Q3 and Strategic Advances

Analyst Sam Slutsky from LifeSci Capital maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) and keeping the price target at $41...

Promising Potential of Oruka Therapeutics' ORKA-001 in Psoriasis Treatment

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) today. The company's shares closed yesterda...

Oruka Therapeutics (ORKA) Gets a Buy from TD Cowen

Oruka Therapeutics (ORKA) announced that it has initiated dosing of healthy volunteers in its first clinical trial of ORKA-001, the Company's novel...

Oruka Therapeutics doses first participants in Phase 1 trial of ORKA-001

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oruka Therapeutics (ORKA – Research Report), Vertex ...

Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Vertex Pharmaceuticals (VRTX)

APLT

VRTX

Press Releases

Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million

Health Care

Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001's Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19

Oruka Therapeutics Announces $200 Million Private Placement

Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress

Oruka Therapeutics to Present at Multiple November Investor Conferences

Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oruka Therapeutics to Present at Piper Sandler's 36th Annual Healthcare Conference

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Comments

Oruka Therapeutics

Oruka Therapeutics (ORKA) Options

Oruka Therapeutics (NASDAQ:ORKA) Stock, Option Chain

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga